{"id":798,"date":"2026-10-20T12:12:53","date_gmt":"2026-10-20T01:12:53","guid":{"rendered":"http:\/\/novameds.local\/au\/?post_type=product&#038;p=798"},"modified":"2026-10-20T12:58:59","modified_gmt":"2026-10-20T01:58:59","slug":"catalog-follistatin-344-1mg","status":"publish","type":"product","link":"https:\/\/novameds.health\/au\/product\/catalog-follistatin-344-1mg\/","title":{"rendered":"Follistatin-344 1mg"},"content":{"rendered":"<section id=\"composition\" data-nav=\"Composition and product details\">\n<h2>Composition and product details<\/h2>\n<div class=\"nm-catalog-document\">\n<div>\n<h2>Overview<\/h2>\n<div>\n<p>Follistatin-344 (FS-344) is the predominant isoform of follistatin, an endogenous glycoprotein that functions as a high-affinity binding protein for multiple members of the TGF-\u03b2 superfamily. By sequestering ligands including activins, myostatin (GDF-8), and selected bone morphogenetic proteins (BMPs), Follistatin-344 prevents receptor engagement and downstream Smad-dependent signal transduction.<\/p>\n<p>Experimental studies have utilized FS-344 to investigate activin receptor signaling, myostatin-associated regulatory pathways, TGF-\u03b2 superfamily biology, ligand-receptor interaction dynamics, and Smad2\/3- and Smad1\/5\/8-mediated transcriptional regulation.<\/p>\n<p>Its broad ligand-binding profile and well-characterized mechanism make Follistatin-344 a valuable research tool for studies of growth factor signaling networks, extracellular ligand sequestration, pathway cross-talk within the TGF-\u03b2 superfamily, and comparative investigations of myostatin and activin antagonism.<\/p>\n<ul>\n<li> <span><b>High Purity<\/b> \u2013 99% Purity Guaranteed<\/span><\/li>\n<li> Independently Lab Tested<\/li>\n<li> Research Grade Quality<\/li>\n<li> For Laboratory Research Use Only<\/li>\n<\/ul><\/div>\n<div>\n<div><span>All SwissChems products are independently third-party tested at a USA-based HPLC-licensed laboratory prior to distribution. Certificates of Analysis (COA) are published on the Independent Test Results page and available at product level. If any independently conducted HPLC test returns a negative result, SwissChems will refund: (1) the cost of the HPLC test, and (2) the full order amount including shipping.<\/span><\/div>\n<div>\n<div><span>Follistatin-344 1mg<\/span><span>1 vial | KIT (10 vials)<\/span><\/div>\n<\/div><\/div>\n<\/p><\/div>\n<div>\n<h2>Properties<\/h2>\n<div class=\"nm-catalog-table\" tabindex=\"0\" role=\"region\" aria-label=\"Product data\">\n<table>\n<tbody>\n<tr>\n<th>Chemical Formula<\/th>\n<td>C203H317N55O64S1<\/td>\n<\/tr>\n<tr>\n<th>Synonyms<\/th>\n<td>Follistatin FST-344, FS-344, Activin-binding protein<\/td>\n<\/tr>\n<tr>\n<th>Molar Mass<\/th>\n<td>~35,000 g\/mol<\/td>\n<\/tr>\n<tr>\n<th>CAS Number<\/th>\n<td>100043-71-8<\/td>\n<\/tr>\n<tr>\n<th>PubChem CID<\/th>\n<td>N\/A<\/td>\n<\/tr>\n<tr>\n<th>Available formats<\/th>\n<td>1 vial \u00b7 KIT (10 vials)<\/td>\n<\/tr>\n<tr>\n<th>Shelf Life<\/th>\n<td>36 months<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div><\/div>\n<div>\n<h2>Research<\/h2>\n<p>\t\t\t\t\t<span>Follistatin-344 (FS-344) is a 344-amino-acid heparin-binding glycoprotein isoform produced through alternative splicing of the FST gene. It functions as a high-affinity extracellular binding protein for multiple TGF-\u03b2 superfamily ligands, including activins, myostatin (GDF-8), and selected bone morphogenetic proteins (BMPs). By sequestering these ligands prior to receptor engagement, FS-344 inhibits downstream Smad2\/3- and Smad1\/5\/8-dependent signaling pathways and modulates TGF-\u03b2 superfamily signal transduction. Experimental investigations have utilized Follistatin-344 to study activin receptor signaling, myostatin-associated regulatory pathways, ligand-receptor interaction dynamics, extracellular growth factor sequestration, and Smad-mediated transcriptional regulation. The FS-344 isoform contains a C-terminal extension that contributes to interactions with heparan sulfate-containing structures, influencing its distribution and localization characteristics relative to other follistatin isoforms. Supplied as lyophilized preparation (1 mg\/vial). Independently third-party HPLC-tested; COA available per batch.<\/span>\t\t\t\t\t<\/div>\n<div>\n<h2>FAQ<\/h2>\n<div>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What is the difference between Follistatin-344 and Follistatin-315, and why does isoform matter for research?<\/span><\/p>\n<\/summary>\n<div>\n<p>Follistatin-344 (FS-344) and Follistatin-315 (FS-315) are alternative splice variants of the FST gene that differ in their C-terminal sequence composition. FS-344 contains an additional peptide region associated with interactions involving heparan sulfate-containing structures, influencing its localization and distribution characteristics.<\/p>\n<p>FS-315 lacks this extension and displays different extracellular distribution properties. These structural differences make isoform selection an important consideration in studies investigating ligand sequestration dynamics, TGF-\u03b2 superfamily signaling, extracellular protein interactions, and growth factor distribution mechanisms.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>Which TGF-\u03b2 superfamily members does follistatin antagonize, and how selective is this interaction?<\/span><\/p>\n<\/summary>\n<div>\n<p>Follistatin functions as a broad-spectrum extracellular binding protein for multiple TGF-\u03b2 superfamily ligands. Its highest-affinity interactions occur with activin family members, while additional binding activity has been documented for myostatin (GDF-8) and selected bone morphogenetic proteins (BMPs).<\/p>\n<p>Because follistatin interacts with several ligand families rather than a single target, it is widely used in studies examining activin signaling, myostatin biology, BMP-associated pathways, receptor-ligand competition, and cross-talk within TGF-\u03b2 superfamily signaling networks.<\/p>\n<\/div>\n<\/details>\n<details>\n<summary>\n\t\t\t\t\t\t\t\t\t\t<span>What experimental evidence supports follistatin&#8217;s role in TGF-\u03b2 superfamily signaling regulation?<\/span><\/p>\n<\/summary>\n<div>\n<p>Extensive experimental research has demonstrated that follistatin modulates TGF-\u03b2 superfamily signaling through direct ligand sequestration, preventing receptor engagement and downstream Smad-dependent signal transduction.<\/p>\n<p>Studies utilizing recombinant protein administration, transgenic expression systems, gene-transfer approaches, and in vitro signaling models have consistently shown suppression of activin-, myostatin-, and BMP-associated signaling pathways.<\/p>\n<p>These findings have established follistatin as a widely used research tool for investigating extracellular growth factor regulation, ligand-neutralization mechanisms, Smad signaling networks, and TGF-\u03b2 superfamily pathway biology.<\/p>\n<\/div>\n<\/details><\/div>\n<\/p><\/div>\n<\/div>\n<\/section>\n","protected":false},"excerpt":{"rendered":"<p>Follistatin-344 (FS-344) is the predominant isoform of follistatin, an endogenous glycoprotein that functions as a high-affinity binding protein for multiple members of the TGF-\u03b2 superfamily.<\/p>\n<p>Presentation: Follistatin-344 1mg.<\/p>\n<p>Select the required strength and pack size.<\/p>\n<p class=\"nm-research-disclaimer\">For laboratory research only. Not for human or veterinary use.<\/p>\n<p class=\"nm-catalog-image-note\"><small>Illustrative packaging generated with AI.<\/small><\/p>\n","protected":false},"featured_media":972,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[26],"product_tag":[],"nm_classification":[],"class_list":["post-798","product","type-product","status-publish","has-post-thumbnail","product_cat-recovery-regeneration","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"_links":{"self":[{"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product\/798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/comments?post=798"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/media\/972"}],"wp:attachment":[{"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/media?parent=798"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product_brand?post=798"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product_cat?post=798"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/product_tag?post=798"},{"taxonomy":"nm_classification","embeddable":true,"href":"https:\/\/novameds.health\/au\/wp-json\/wp\/v2\/nm_classification?post=798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}